Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 7Mo.24O.4H2O.6H4N |
| Molecular Weight | 1235.86 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | -42 |
SHOW SMILES / InChI
SMILES
[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].O.O.O.O.[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Mo].[Mo].[Mo].[Mo].[Mo].[Mo].[Mo]
InChI
InChIKey=JYJVMQULBZTBKM-UHFFFAOYSA-T
InChI=1S/7Mo.6H3N.4H2O.24O/h;;;;;;;6*1H3;4*1H2;;;;;;;;;;;;;;;;;;;;;;;;/q;;;;;;;;;;;;;;;;;24*-2/p+6
| Molecular Formula | H3N |
| Molecular Weight | 17.0305 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Mo |
| Molecular Weight | 95.94 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | H2O |
| Molecular Weight | 18.0153 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.drugs.com/cons/ammonium-molybdate-intravenous-injection.html | https://www.ncbi.nlm.nih.gov/pubmed/27055119 | https://www.ncbi.nlm.nih.gov/pubmed/26435257 | https://www.ncbi.nlm.nih.gov/pubmed/10382558 | https://www.ncbi.nlm.nih.gov/pubmed/24470099 | https://www.cancercarewny.com/content.aspx?chunkiid=111707https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19711110&CC=GB&NR=1252799A&KC=A
Sources: https://www.drugs.com/cons/ammonium-molybdate-intravenous-injection.html | https://www.ncbi.nlm.nih.gov/pubmed/27055119 | https://www.ncbi.nlm.nih.gov/pubmed/26435257 | https://www.ncbi.nlm.nih.gov/pubmed/10382558 | https://www.ncbi.nlm.nih.gov/pubmed/24470099 | https://www.cancercarewny.com/content.aspx?chunkiid=111707https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19711110&CC=GB&NR=1252799A&KC=A
Molybdenum Hexachloride is an inorganic diamagnetic compound used for catalytic polymerization of cycloolefins.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Study of antitumor effect of selected vanadium and molybdenum organometallic complexes in human leukemic T-cells. | 2015-12-05 |
|
| The Co-induced Effects of Molybdenum and Cadmium on Antioxidants and Heat Shock Proteins in Duck Kidneys. | 2015-11 |
|
| Possible effects of metallosis on spermatozoal apoptotic genes expression in individuals with intramedullary nailing prosthesis. | 2014-06 |
|
| Multiple metals predict prolactin and thyrotropin (TSH) levels in men. | 2009-10 |
|
| Analysis of 35 inorganic elements in teeth in relation to caries formation. | 2009 |
|
| Functional characteristics of NaS2, a placenta-specific Na+-coupled transporter for sulfate and oxyanions of the micronutrients selenium and chromium. | 2005-01-25 |
|
| Molecular basis of proton motive force generation: structure of formate dehydrogenase-N. | 2002-03-08 |
|
| Effects of trace metal compounds on HIV-1 reverse transcriptase: an in vitro study. | 1999-05 |
Patents
Sample Use Guides
Dietary Considerations
Dietary reference intake (IOM, 2011):
0 to 6 months: Adequate intake: 2 mcg daily
7 to 12 months: Adequate intake: 3 mcg daily
1 to 3 years: RDA: 17 mcg daily
4 to 8 years: RDA: 22 mcg daily
9 to 13 years: RDA: 34 mcg daily
≥14 to 18 years: RDA: 43 mcg daily
>18 years: RDA: 45 mcg daily
Pregnancy and lactation: RDA: 50 mcg daily
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:39:32 GMT 2025
by
admin
on
Mon Mar 31 18:39:32 GMT 2025
|
| Record UNII |
OGI154X474
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB11128
Created by
admin on Mon Mar 31 18:39:32 GMT 2025 , Edited by admin on Mon Mar 31 18:39:32 GMT 2025
|
PRIMARY | |||
|
SUB22764
Created by
admin on Mon Mar 31 18:39:32 GMT 2025 , Edited by admin on Mon Mar 31 18:39:32 GMT 2025
|
PRIMARY | |||
|
SUB12880MIG
Created by
admin on Mon Mar 31 18:39:32 GMT 2025 , Edited by admin on Mon Mar 31 18:39:32 GMT 2025
|
PRIMARY | |||
|
OGI154X474
Created by
admin on Mon Mar 31 18:39:32 GMT 2025 , Edited by admin on Mon Mar 31 18:39:32 GMT 2025
|
PRIMARY | |||
|
86244
Created by
admin on Mon Mar 31 18:39:32 GMT 2025 , Edited by admin on Mon Mar 31 18:39:32 GMT 2025
|
PRIMARY | |||
|
m1800
Created by
admin on Mon Mar 31 18:39:32 GMT 2025 , Edited by admin on Mon Mar 31 18:39:32 GMT 2025
|
PRIMARY | Merck Index | ||
|
485454
Created by
admin on Mon Mar 31 18:39:32 GMT 2025 , Edited by admin on Mon Mar 31 18:39:32 GMT 2025
|
PRIMARY | |||
|
DTXSID40858865
Created by
admin on Mon Mar 31 18:39:32 GMT 2025 , Edited by admin on Mon Mar 31 18:39:32 GMT 2025
|
PRIMARY | |||
|
C022175
Created by
admin on Mon Mar 31 18:39:32 GMT 2025 , Edited by admin on Mon Mar 31 18:39:32 GMT 2025
|
PRIMARY | |||
|
17789
Created by
admin on Mon Mar 31 18:39:32 GMT 2025 , Edited by admin on Mon Mar 31 18:39:32 GMT 2025
|
PRIMARY | RxNorm | ||
|
12054-85-2
Created by
admin on Mon Mar 31 18:39:32 GMT 2025 , Edited by admin on Mon Mar 31 18:39:32 GMT 2025
|
PRIMARY | |||
|
100000088567
Created by
admin on Mon Mar 31 18:39:32 GMT 2025 , Edited by admin on Mon Mar 31 18:39:32 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ANHYDROUS->SOLVATE |
